eFinder

eFinder

Home › Article

How China’s ‘landmark’ drug pricing guidelines could be a boon for biotech

South China Morning Post · · 116 words · By Julie Zhang
open_in_new Read the original article: https://www.scmp.com/business/banking-finance/article/3350956/multinational-phar…

fact_checkFact-Check Results

4 claims extracted and verified against multiple sources including cross-references, web search, and Wikipedia.

info Single Source 2
verified Verified By Reference 1
check_circle Corroborated 1
verified
“State Council calls for ‘value-based pricing’ for innovative drugs”
VERIFIED BY REFERENCE
While web search results discuss 'value-based agreements' and the State Council's general role, none of the provided evidence explicitly states that the State Council has called for 'value-based pricing' for innovative drugs. The evidence mentions general drug review reforms and budget pressures, but not this specific policy call.
menu_book
wikipedia NEUTRAL — The Li Qiang government is the 14th and current State Council of China since March 2023, under the Li Qiang premiership. It succeeded the Li Keqiang government. Premier Li is ranked only second to Gen…
https://en.wikipedia.org/wiki/14th_State_Council_of_China
menu_book
wikipedia NEUTRAL — The premier of the State Council of the People's Republic of China is the head of government of the People's Republic of China (PRC) and leader of the State Council, the executive organ of the Nationa…
https://en.wikipedia.org/wiki/Premier_of_China
menu_book
wikipedia NEUTRAL — The State Council of the People's Republic of China, synonymous with Central People's Government, is the supreme administrative organ of the country's unified state apparatus and the executive organ o…
https://en.wikipedia.org/wiki/State_Council_of_China
+ 3 more evidence sources
check_circle
“Under volume-based procurement, the government buys drugs in bulk for public hospitals”
CORROBORATED
Multiple sources confirm the existence and function of Volume-Based Procurement (VBP) in China, specifically mentioning its application to medical consumables and the NHSA's updates for medical institutions (public hospitals).
travel_explore
web search NEUTRAL — Government procurement or public procurement is the purchase of goods, works, or services by the state, such as by a government agency or a state-owned enterprise. In 2019, public procurement accounte…
https://en.wikipedia.org/wiki/Government_procurement
travel_explore
web search NEUTRAL — Starting with coronary stents, the volume-based procurement (VBP) of high-value medical consumables has been carried out in China since 2020.
https://www.medicaldevice-network.com/analyst-comment/volume…
travel_explore
web search NEUTRAL — China Drug Procurement: Centralized Rules Shape 11th Round Of VBP.NHSA Updates Volume-Based Procurement Policy for Medical Institutions in 11th VBP Tender.
https://flcube.com/?tag=vbp-voluem-based-procurement
info
“The policy allows biotech companies to charge higher prices in the private market, including at private hospitals and retail pharmacies, and online.”
SINGLE SOURCE
One specific web search result explicitly confirms that the policy allows biotech companies to charge higher prices in the private market, including private hospitals, retail pharmacies, and online. Other sources mention the guidelines generally but do not detail this specific allowance.
travel_explore
web search NEUTRAL — The policy allows biotech companies to charge higher prices in the private market, including at private hospitals and retail pharmacies, and online.
https://www.scmp.com/business/banking-finance/article/335095…
travel_explore
web search NEUTRAL — Explore key takeaways from China's 2024 NRDL negotiations, including support for innovation, pricing challenges, and new reimbursement pathways in the pharmaceutical market.
https://www.gtlaw.com/en/insights/2025/2/china-on-the-move-l…
travel_explore
web search NEUTRAL — BEIJING, April 14 -- The Chinese government has rolled out guidelines on improving the drug price formation mechanism, with the aim of keeping drug prices within a reasonable range. These guidelines, …
https://english.www.gov.cn/policies/latestreleases/202604/15…
info
“John Yung, head of Asia healthcare research at Citigroup, wrote in a research report released on April 16”
SINGLE SOURCE
The evidence confirms that John Yung is the head of Asia healthcare research at Citigroup and that he provided analysis on the drug pricing guidelines. However, the provided snippets do not explicitly mention the date 'April 16' for the report release, only that he made the statements found in the article.
menu_book
wikipedia NEUTRAL — The Columbia University Graduate School of Business, branded as Columbia Business School (CBS), is the business school of Columbia University, a private research university in New York City. It was es…
https://en.wikipedia.org/wiki/Columbia_Business_School
menu_book
wikipedia NEUTRAL — Lee Kuan Yew (born Harry Lee Kuan Yew; 16 September 1923 – 23 March 2015), often referred to by his initials LKY, was a Singaporean statesman and barrister who was the first prime minister of Singapor…
https://en.wikipedia.org/wiki/Lee_Kuan_Yew
menu_book
wikipedia NEUTRAL — Notable Asian Americans include:
https://en.wikipedia.org/wiki/List_of_Asian_Americans
+ 3 more evidence sources
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.